Picture of Marlowe logo

MRL Marlowe News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsSpeculativeMid CapNeutral

REG - Marlowe PLC - Exercise of Share Options and Total Voting Rights

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230808:nRSH5615Ia&default-theme=true

RNS Number : 5615I  Marlowe PLC  08 August 2023

8 August 2023

 

Marlowe plc

("Marlowe" or the "Company")

 

Exercise of Share Options under 2020 SAYE Scheme

 

Total Voting Rights

 

The Company announces that, as a result of an exercise of employee share
options under the Marlowe 2020 SAYE Scheme, application has been made for
2,217 new ordinary shares of 50 pence each in the Company (the "New Ordinary
Shares") to be admitted to trading on AIM.

The New Ordinary Shares will rank pari passu with the Company's existing
ordinary shares and it is expected that admission will occur at 8.00
a.m. on 11 August 2023.

 

Following admission of the New Ordinary Shares, the Company's issued ordinary
share capital will comprise 96,481,891 ordinary shares, none of which are held
in treasury. Therefore, the total number of ordinary shares with voting rights
in Marlowe following admission will be 96,481,891.

 

The above figure of 96,481,891 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in the Company under
the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information:

 Marlowe plc
 Alex Dacre, Chief Executive                     www.marloweplc.com (http://www.marloweplc.com)
 Adam Councell, Chief Financial Officer          Tel: +44 (0) 203 813 8498
 Benjamin Tucker, Investor Relations Manager

 Cenkos Securities plc (Nominated Adviser and Joint Broker)
 Ben Jeynes                                      Tel: +44 (0)20 7397 8900
 George Lawson

 Berenberg (Joint Broker)
 Ben Wright              Tel: +44 (0)20 3207 7800
 Mark Whitmore

 Stifel (Joint Broker)
 Matthew Blawat          Tel: +44 (0)20 7710 7688
 Francis North

 FTI Consulting
 Nick Hasell             Tel: +44 (0)20 3727 1340
 Alex Le May

 

 

 

 

 

 

 

 

About Marlowe plc

Marlowe is a leader in business-critical services and software which assure
regulatory compliance. The company was formed to create sustainable
shareholder value through the acquisition and development of businesses that
provide regulated safety and compliance services and software. It is focused
on compliance software, eLearning, health & safety, employment law &
HR compliance, fire safety & security, water & air hygiene and
occupational health services - all of which are vital to the wellbeing of its
customers operations and are invariably governed by regulation. Marlowe
currently provides software to over 1 million users and services to over 25%
of Britain's commercial premises. The Group provides customers with a single
outsourced, nationwide, provider of a range of regulated compliance and safety
solutions. Our customers can be found in office complexes, high streets &
leisure facilities, manufacturing plants and industrial estates, and include
thousands of SMEs, local authorities, facilities management providers,
multi-site NHS trusts and FTSE 100 companies.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ALSPRMFTMTJMBMJ

Recent news on Marlowe

See all news